Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer
The investigational Trop2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) continued to demonstrate superiority to chemotherapy for patients with metastatic endocrine-resistant ...
Read more
